Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Jounce Therapeutics, Inc. | Director | Common Stock | 50.5K | $93.4K | $1.85 | Nov 12, 2021 | Direct |
Jounce Therapeutics, Inc. | Director | Common Stock | 0 | $1.85 | Nov 12, 2021 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JNCE | Jounce Therapeutics, Inc. | Nov 12, 2021 | 1 | $0 | 4 | Nov 16, 2021 | Director |
JNCE | Jounce Therapeutics, Inc. | Sep 15, 2021 | 1 | $0 | 4 | Sep 17, 2021 | Director |
JNCE | Jounce Therapeutics, Inc. | Jun 18, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |
JNCE | Jounce Therapeutics, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |